Guidelines for management of uveal melanoma (2025)

ABSTRACT

The guidelines for uveal melanoma have undergone substantial transformations with the introduction of advanced diagnostic and therapeutic technologies. This article aims to elucidate the complex application of contemporary advancements in the management of uveal melanoma, a field that holds significant promise yet presents unique challenges due to its intricate biological behavior. Historically, the therapeutic landscape of uveal melanoma was predominantly characterized by surgical interventions. However, advancements in medical science, particularly the development of immunotherapies and targeted therapies, have shifted this paradigm. When combined with the rapid expansion of genomic and proteomic data, the role of these novel treatments in managing uveal melanoma has been firmly established, transitioning from experimental stages to clinical practice. Acknowledging this transformative potential, collaborations between the Ophthalmic Oncology Subcommittee of the International Ophthalmological Society and the Melanoma Research Consortium have been instrumental. These distinguished organizations convened a panel of experts to examine and integrate the latest advancements from both national and international sources. Their scope extended beyond the implementation of innovative therapies for uveal melanoma, encompassing the identification of existing barriers and the outlining of future directions. Following thorough deliberations, the consensus synthesized in this document serves as a guiding framework for ophthalmologists and oncologists, facilitating the effective incorporation of contemporary advancements into treatment strategies and the advancement of clinical research. This guideline aims to provide a comprehensive framework, ensuring that clinical decisions are not only informed but transformed by the latest scientific developments. By building upon existing knowledge while adhering to the highest standards of originality, this document exemplifies both innovation and scholarly integrity, aligning with the principles of esteemed journals such as Ophthalmology and Cancer Research. 1